@article{https://doi.org/10.3204/pubdb-2023-00887,<br/><span class="tab"></span>
  doi = {10.3204/PUBDB-2023-00887},<br/><span class="tab"></span>
  url = {https://bib-pubdb1.desy.de/record/576716},<br/><span class="tab"></span>
  author = {Oerlemans,<br/><span class="tab"></span> Rick and Ruiz-Moreno,<br/><span class="tab"></span> Angel Jonathan and Cong,<br/><span class="tab"></span> Yingying and Dinesh Kumar,<br/><span class="tab"></span> Nilima and Velasco-Velazquez,<br/><span class="tab"></span> Marco A and Neochoritis,<br/><span class="tab"></span> Constantinos G and Smith,<br/><span class="tab"></span> Jolanda and Reggiori,<br/><span class="tab"></span> Fulvio and Groves,<br/><span class="tab"></span> Matthew R and Dömling,<br/><span class="tab"></span> Alexander},<br/><span class="tab"></span>
  keywords = {540},<br/><span class="tab"></span>
  language = {en},<br/><span class="tab"></span>
  title = {Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics.},<br/><span class="tab"></span>
  journal = {RSC medicinal chemistry 12(3)},<br/><span class="tab"></span>
  pages = {370-379 (2020). doi:10.1039/D0MD00367K},<br/><span class="tab"></span>
  publisher = {Deutsches Elektronen-Synchrotron,<br/><span class="tab"></span> DESY,<br/><span class="tab"></span> Hamburg},<br/><span class="tab"></span>
  year = {2020}
}